Cargando…
Suppression of Pyk2 Kinase and Cellular Activities by Fip200
Proline-rich tyrosine kinase 2 (Pyk2) is a cytoplasmic tyrosine kinase implicated to play a role in several intracellular signaling pathways. We report the identification of a novel Pyk2-interacting protein designated FIP200 (FAK family kinase–interacting protein of 200 kD) by using a yeast two-hybr...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175150/ https://www.ncbi.nlm.nih.gov/pubmed/10769033 |
_version_ | 1782145425045716992 |
---|---|
author | Ueda, Hiroki Abbi, Smita Zheng, Chuanhai Guan, Jun-Lin |
author_facet | Ueda, Hiroki Abbi, Smita Zheng, Chuanhai Guan, Jun-Lin |
author_sort | Ueda, Hiroki |
collection | PubMed |
description | Proline-rich tyrosine kinase 2 (Pyk2) is a cytoplasmic tyrosine kinase implicated to play a role in several intracellular signaling pathways. We report the identification of a novel Pyk2-interacting protein designated FIP200 (FAK family kinase–interacting protein of 200 kD) by using a yeast two-hybrid screen. In vitro binding assays and coimmunoprecipitation confirmed association of FIP200 with Pyk2, and similar assays also showed FIP200 binding to FAK. However, immunofluorescent staining indicated that FIP200 was predominantly localized in the cytoplasm. FIP200 bound to the kinase domain of Pyk2 and inhibited its kinase activity in in vitro kinase assays. FIP200 also inhibited the kinase activity of the Pyk2 isolated from SYF cells (deficient in Src, Yes, and Fyn expression) and the Pyk2 mutant lacking binding site for Src, suggesting that it regulated Pyk2 kinase directly rather than affecting the associated Src family kinases. Consistent with its inhibitory effect in vitro, FIP200 inhibited activation of Pyk2 and Pyk2-induced apoptosis in intact cells, which correlated with its binding to Pyk2. Finally, activation of Pyk2 by several biological stimuli correlated with the dissociation of endogenous FIP200–Pyk2 complex, which provided further support for inhibition of Pyk2 by FIP200 in intact cells. Together, these results suggest that FIP200 functions as an inhibitor of Pyk2 via binding to its kinase domain. |
format | Text |
id | pubmed-2175150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2000 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21751502008-05-01 Suppression of Pyk2 Kinase and Cellular Activities by Fip200 Ueda, Hiroki Abbi, Smita Zheng, Chuanhai Guan, Jun-Lin J Cell Biol Original Article Proline-rich tyrosine kinase 2 (Pyk2) is a cytoplasmic tyrosine kinase implicated to play a role in several intracellular signaling pathways. We report the identification of a novel Pyk2-interacting protein designated FIP200 (FAK family kinase–interacting protein of 200 kD) by using a yeast two-hybrid screen. In vitro binding assays and coimmunoprecipitation confirmed association of FIP200 with Pyk2, and similar assays also showed FIP200 binding to FAK. However, immunofluorescent staining indicated that FIP200 was predominantly localized in the cytoplasm. FIP200 bound to the kinase domain of Pyk2 and inhibited its kinase activity in in vitro kinase assays. FIP200 also inhibited the kinase activity of the Pyk2 isolated from SYF cells (deficient in Src, Yes, and Fyn expression) and the Pyk2 mutant lacking binding site for Src, suggesting that it regulated Pyk2 kinase directly rather than affecting the associated Src family kinases. Consistent with its inhibitory effect in vitro, FIP200 inhibited activation of Pyk2 and Pyk2-induced apoptosis in intact cells, which correlated with its binding to Pyk2. Finally, activation of Pyk2 by several biological stimuli correlated with the dissociation of endogenous FIP200–Pyk2 complex, which provided further support for inhibition of Pyk2 by FIP200 in intact cells. Together, these results suggest that FIP200 functions as an inhibitor of Pyk2 via binding to its kinase domain. The Rockefeller University Press 2000-04-17 /pmc/articles/PMC2175150/ /pubmed/10769033 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Original Article Ueda, Hiroki Abbi, Smita Zheng, Chuanhai Guan, Jun-Lin Suppression of Pyk2 Kinase and Cellular Activities by Fip200 |
title | Suppression of Pyk2 Kinase and Cellular Activities by Fip200 |
title_full | Suppression of Pyk2 Kinase and Cellular Activities by Fip200 |
title_fullStr | Suppression of Pyk2 Kinase and Cellular Activities by Fip200 |
title_full_unstemmed | Suppression of Pyk2 Kinase and Cellular Activities by Fip200 |
title_short | Suppression of Pyk2 Kinase and Cellular Activities by Fip200 |
title_sort | suppression of pyk2 kinase and cellular activities by fip200 |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2175150/ https://www.ncbi.nlm.nih.gov/pubmed/10769033 |
work_keys_str_mv | AT uedahiroki suppressionofpyk2kinaseandcellularactivitiesbyfip200 AT abbismita suppressionofpyk2kinaseandcellularactivitiesbyfip200 AT zhengchuanhai suppressionofpyk2kinaseandcellularactivitiesbyfip200 AT guanjunlin suppressionofpyk2kinaseandcellularactivitiesbyfip200 |